subject area of
- Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis Academic Article
- Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: Results of a Canadian multicenter, open-label trial Academic Article
- Efficacy of Desloratadine in Persistent Allergic Rhinitis – A GA<sup>2</sup>LEN Study Academic Article
- Efficacy of desloratadine in intermittent allergic rhinitis: a GA 2 LEN study Academic Article
- Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction Academic Article
- Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms Academic Article
- Reported Case of Severe Hepatotoxicity Likely due to Fluconazole and <i>Not</i> Desloratadine Academic Article
- Rhinitis management: the patient’s perspective Academic Article
- Single-dose desloratadine and montelukast and allergen-induced late airway responses Academic Article
- Suppression of histamine- and allergen-induced skin reactions: comparison of first- and second-generation antihistamines Academic Article
- The Effect of Desloratadine on Eosinophil/Basophil Progenitors and Other Inflammatory Markers in Seasonal Allergic Rhinitis: A Placebo-Controlled Randomized Study Academic Article